Results 101 to 110 of about 28,908 (228)
Clinical Case Reports, Volume 14, Issue 6, June 2026.ABSTRACT Herpes zoster ophthalmicus (HZO) refers to reactivation of varicella–zoster virus involving the ophthalmic division of the trigeminal nerve. Guillain‐Barré syndrome (GBS) has been infrequently reported following herpes zoster infection, and its occurrence after HZO is particularly uncommon.
Asad Ullah Khan +8 more
wiley +1 more source
Application of ozone and plasmapheresis in complex treatment of uveitis
, 2009 A new method of treatment of endogenous uveitis have been developed. The method is based on the application of metabolic plasmapheresis with ozonization of cellular weight.
A. D. Chernyshyova
core +1 more source
Case Report: Recurrent Guillain–Barré Syndrome in a 56‐Year‐Old Male
Clinical Case Reports, Volume 14, Issue 6, June 2026.ABSTRACT Recurrent Guillain–Barré syndrome (GBS) is an uncommon variant of immune‐mediated polyradiculoneuropathy. We report a 56‐year‐old male who had two distinct episodes of acute inflammatory demyelinating neuropathy within the span of 3 months. The first episode presented with an episode of ascending paralysis and areflexia, with nerve conduction ...
Farah Sadiq +8 more
wiley +1 more source
Clinical Case Reports, Volume 14, Issue 6, June 2026.ABSTRACT Paraneoplastic pemphigus (PNP) is a life‐threatening autoimmune blistering disease with a mortality rate of 70%–90%, driven largely by respiratory complications such as bronchiolitis obliterans. Managing respiratory failure in these patients remains exceptionally difficult.
Lu Li +5 more
wiley +1 more source
Clinical Case Reports, Volume 14, Issue 6, June 2026.ABSTRACT Optic neuritis is an acute inflammatory disease that can cause acute visual loss. We present a case of a 22‐year‐old female in postpartum with acute headache, retroocular pain, and bilateral amaurosis. Orbit MRI revealed inflammatory changes in both neurovascular optical bundles.
Jose Luis Rojas‐Oviedo +5 more
wiley +1 more source
Plasmapheresis in a patient with scleromyxedema.
, 1987 We describe a patient with progressive scleromyxedema who failed to respond to previously described treatment modalities. A trial of plasmapheresis was initiated, but after an initial promising response, his disease continued to progress.
Lookingbill, D P, Westheim, A I
core
, 2019 Background: Mycophenolic acid (MPA), a crucial immunosuppressive drug, and plasmapheresis, an effective immunoreduction method, are simultaneously used for the management of various immune-related diseases, including kidney transplantation.
Kearkiat Praditpornsilpa +10 more
core +1 more source
Can Plasma Exchange Be Used to Lower the Circulating Burden of Microplastics in Human Patients?
Journal of Clinical Apheresis, Volume 41, Issue 3, June 2026.ABSTRACT Microplastic particles (MP) from industrial products and degradation of plastic waste are ubiquitous in our environment and convey serious potential risks to human health. There is currently no established method for removing MP from the human body.
Robert Weinstein +12 more
wiley +1 more source
Extracorporeal Methods of Detoxification in Generalized Peritonitis
Общая реаниматология, 2008 Objective: to optimize the results of treatment in patients with generalized peritonitis. Sixty-eight patients were examined. In Group 1 (n=26), plasmapheresis was performed during traditional therapy; in Group 2 (n=28) plasmapheresis was combined with ...
O. M. Shevtsova +4 more
doaj +1 more source
Plasmapheresis for treatment of pulmonary alveolar proteinosis.
, 2009 Whole lung lavage (WLL) is currently the standard therapy for pulmonary alveolar proteinosis (PAP). Nevertheless, some PAP patients respond poorly to WLL or require it frequently.
B. C. Trapnell +6 more
core +1 more source